月期刊平台服务过的文章录用时间为1-3个月，依据20年经验，经月期刊专家预审通过后的文章，投稿通过率100%以上！
《血液学治疗进展》(TAH)是一份经过同行评审的开放获取期刊，专注于发表高质量的同行评审文章、评论，并对血液学各个领域的开创性努力和创新研究发表学术评论。更多信息请参见Aims和Scope选项卡。
Therapeutic Advances in Hematology (TAH) is a peer-reviewed open access journal which focuses on delivering the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of hematology. Please see the Aims and Scope tab for further information.
